UnitedHealth Group, April 2025.

A 72-hour framing window that either preserved or destroyed market capitalization. The communications pod chose one of five possible verbatims. The choice destroyed the fastest.

Single-day market cap loss

$115B

22% drop · worst day in 25+ years · compounding to $280–300B over 26 days

T=0

2025-04-16

Evening before the 05:55 ET release

01 / The decision

Five verbatims on the table. One window to pick.

UnitedHealth Group walked into Q1 2025 earnings on 17 April in the most fragile communications environment any F500 CCO had faced in a decade. The post-Brian-Thompson context was still live. The DOJ Medicare Advantage billing-practices probe had been public since mid-February. Senator Grassley's oversight interest was known. Utilization trends were deteriorating inside the Medicare Advantage book, guidance was going to have to move, and the framing of how and why it moved was the only lever the Chief Communications Officer had left in the short window before the market opened on Thursday morning.

That is the archetype. A Chief Communications Officer at a Fortune 500 facing a 72-hour window in which the framing of an earnings release, a guidance cut, or a crisis disclosure either preserves or destroys market capitalization. The room has five candidate framings. The room cannot empirically test any of them. The decision is made by internal judgment, with one shot, and the scale of consequence is measured in tens of billions of dollars.

On 17 April 2025 at 05:55 ET, UnitedHealth Group released Q1 2025 earnings and cut full-year guidance. The stock fell 22% on the day — $115 billion of market capitalization destroyed in a single session, the worst day for UnitedHealth in more than 25 years. The compounding narrative arc over the following 26 days — earnings guidance suspended, DOJ investigation resurfaced in tier-1 coverage, Senator Grassley's letter, CEO Andrew Witty's 13 May resignation — destroyed a cumulative $280 to 300 billion before the narrative stabilized.

T=0 / The cutoff

Evening of 16 April 2025.

The rehearsal was run on the evening of 16 April 2025, using only documents a UnitedHealth crisis pod would plausibly have had in working memory at that moment — the actuarial review on the Medicare Advantage utilization trend, the DOJ probe coverage trail, prior-quarter comments on the guidance band, the draft Q1 release, and the five framing options the communications room was debating.

Held out of the rehearsal and never uploaded to Glasshouse: the 17 April release itself, the 22% single-day drop, Senator Grassley's letter, every piece of post-release tier-1 coverage, and the 13 May CEO resignation. Gemma 4's training cutoff is January 2025; the April 2025 earnings event is three and a half months post-cutoff. Clean simulation territory.

02 / The rehearsal

What Glasshouse produced.

The rehearsal surfaced five candidate framings for the release and ranked them by structural damage inside the simulation's dominant narrative trajectory. The framing that read in the room as the most controlled and decisive — the "unusual and unacceptable" verbatim the company eventually used — was flagged by Glasshouse as the single most structurally-damaging option before the release landed. 1 The reasoning from the institutional-investor personas inside the simulation was specific: the verbatim invited tier-1 coverage to re-examine the DOJ probe and the utilization trend together, and once that re-examination was under way the compounding narrative arc was structurally difficult to exit.

The simulation predicted the 22% single-day drop inside the round-ten narrative ranking and flagged the DOJ-resurfacing effect as an expected property of the tier-1 follow-up coverage rather than an exogenous shock. 2 The alternative framing options the rehearsal ranked above "unusual and unacceptable" — a Medicare-specific attribution, a utilization-trend disclosure tied to actuarial data, a guidance-suspension pre-announcement — each landed at materially lower simulated damage.

The specific recommendation coming out of the rehearsal was to separate the guidance cut from a framing that invited a re-examination of the DOJ trail, and to lead with the Medicare Advantage utilization data as the attribution anchor. 3

03 / What actually happened

Rehearsal alongside record.

Glasshouse rehearsal · T=0 2025-04-16

Framings ranked by structural damage

01 “Unusual and unacceptable” — ranked highest risk
02 Medicare-specific attribution
03 Utilization-trend disclosure
04 Guidance-suspension pre-announcement
05 Delayed release with board note

Round-ten simulated narrative placed the 22% single-day drop and the DOJ-resurfacing arc before the release landed.

Real-world record · 17 April to 13 May 2025

Documented reaction

01 Stock down 22% on 17 April — worst day for UnitedHealth in 25+ years
02 DOJ Medicare Advantage probe resurfaced in tier-1 follow-up coverage
03 Earnings guidance suspended in the weeks following the release
04 Senator Grassley letter — oversight inquiry made public
05 CEO Andrew Witty resigned on 13 May 2025

Primary reporting from Bloomberg, Reuters, Fortune, CNBC, and Financial Times coverage dated 17 April to 13 May 2025.

The rehearsal cost is a fraction of a percent of the value it could have preserved. The compounding narrative arc is the interesting number, not the single-day drop.

04 / Methodology

Four rules. No exceptions.

Rule / 01

T=0 is explicit.

T=0 for this case is the evening of 16 April 2025, the night before the 05:55 ET release. The seed contains only documents a UnitedHealth crisis pod would have had in working memory at that moment.

Rule / 02

T=0 is post-cutoff.

Gemma 4's training cutoff is January 2025. The 17 April earnings event and every piece of post-release reporting are three and a half months post-cutoff. The model has no memorized reaction to retrieve from training data.

Rule / 03

Financial anchors are real.

The $115 billion single-day number, the $280 to 300 billion compounding arc, the 22% drop, and the 26-day timeline come from primary reporting in Bloomberg, Reuters, Fortune, and CNBC. Every number on this page is verifiable.

Rule / 04

Never tuned to pass this case.

Glasshouse is tuned on aggregate eval results across many scenarios. This case passes the rubric as a byproduct of aggregate tuning, not because Glasshouse was reverse-engineered around the April 2025 release.

05 / Related rehearsals